|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Youlden DR, Cramb SM and Baade PD: The
international epidemiology of lung cancer: Geographical
distribution and secular trends. J Thorac Oncol. 3:819–831. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Riihimäki M, Hemminki A, Fallah M, Thomsen
H, Sundquist K, Sundquist J and Hemminki K: Metastatic sites and
survival in lung cancer. Lung Cancer. 86:78–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tamura T, Kurishima K, Nakazawa K,
Kagohashi K, Ishikawa H, Satoh H and Hizawa N: Specific organ
metastases and survival in metastatic non-small-cell lung cancer.
Mol Clin Oncol. 3:217–221. 2015. View Article : Google Scholar
|
|
5
|
Nishida N, Yano H, Nishida T, Kamura T and
Kojiro M: Angiogenesis in cancer. Vasc Health Risk Manag.
2:213–219. 2006. View Article : Google Scholar
|
|
6
|
Noman MZ, Messai Y, Muret J, Hasmim M and
Chouaib S: Crosstalk between CTC, immune system and hypoxic tumor
microenvironment. Cancer Microenviron. 7:153–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Popper HH: Progression and metastasis of
lung cancer. Cancer Metastasis Rev. 35:75–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gout S, Tremblay PL and Huot J: Selectins
and selectin ligands in extravasation of cancer cells and organ
selectivity of metastasis. Clin Exp Metastasis. 25:335–344. 2008.
View Article : Google Scholar
|
|
9
|
Ding D, Yao Y, Zhang S, Su C and Zhang Y:
C-type lectins facilitate tumor metastasis. Oncol Lett. 13:13–21.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barthel SR, Gavino JD, Descheny L and
Dimitroff CJ: Targeting selectins and selectin ligands in
inflammation and cancer. Expert Opin Ther Targets. 11:1473–1491.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ogawa J, Sano A, Inoue H and Koide S:
Expression of Lewis-related antigen and prognosis in stage I
non-small cell lung cancer. Ann Thorac Surg. 59:412–415. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizuguchi S, Nishiyama N, Iwata T, Nishida
T, Izumi N, Tsukioka T, Inoue K, Kameyama M and Suehiro S: Clinical
value of serum cytokeratin 19 fragment and sialyl-Lewis X in
non-small cell lung cancer. Ann Thorac Surg. 83:216–221. 2007.
View Article : Google Scholar
|
|
13
|
Komatsu H, Mizuguchi S, Izumi N, Chung K,
Hanada S, Inoue H, Suehiro S and Nishiyama N: Sialyl Lewis X as a
predictor of skip N2 metastasis in clinical stage IA non-small cell
lung cancer. World J Surg Oncol. 11:3092013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Satoh H, Ishikawa H, Kamma H, Yamashita
YT, Takahashi H, Ohtsuka M and Hasegawa S: Elevated serum sialyl
Lewis X-i antigen levels in non-small cell lung cancer with lung
metastasis. Respiration. 65:295–298. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gomes C, Osório H, Pinto MT, Campos D,
Oliveira MJ and Reis CA: Expression of ST3GAL4 leads to SLe(x)
expression and induces c-Met activation and an invasive phenotype
in gastric carcinoma cells. PLoS One. 8:pp. e667372013, View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dall'Olio F, Malagolini N, Trinchera M and
Chiricolo M: Sialosignaling: Sialyltransferases as engines of
self-fueling loops in cancer progression. Biochim Biophys Acta.
1840:2752–2764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dall'Olio F, Malagolini N, Trinchera M and
Chiricolo M: Mechanisms of cancer-associated glycosylation changes.
Front Biosci (Landmark Ed). 17:pp. 670–699. 2012
|
|
18
|
Sperandio M: Selectins and
glycosyltransferases in leukocyte rolling in vivo. FEBS J.
273:4377–4389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakayama F, Nishihara S, Iwasaki H, Kudo
T, Okubo R, Kaneko M, Nakamura M, Karube M, Sasaki K and Narimatsu
H: CD15 expression in mature granulocytes is determined by
α1,3-fucosyltransferase IX, but in promyelocytes and monocytes by
α1,3-fucosyltransferase IV. J Biol Chem. 276:16100–16106. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian L, Shen D, Li X, Shan X, Wang X, Yan
Q and Liu J: Ginsenoside Rg3 inhibits epithelial-mesenchymal
transition (EMT) and invasion of lung cancer by down-regulating
FUT4. Oncotarget. 7:1619–1632. 2016. View Article : Google Scholar :
|
|
21
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours. John Wiley
& Sons, Ltd; 2017
|
|
22
|
Guo C, Liu S and Sun MZ: Novel insight
into the role of GAPDH playing in tumor. Clin Transl Oncol.
15:167–172. 2013. View Article : Google Scholar
|
|
23
|
Guo C, Liu S, Wang J, Sun MZ and Greenaway
FT: ACTB in cancer. Clin Chim Acta. 417:39–44. 2013. View Article : Google Scholar
|
|
24
|
Cucchiarelli V, Hiser L, Smith H,
Frankfurter A, Spano A, Correia JJ and Lobert S: β-tubulin isotype
classes II and V expression patterns in nonsmall cell lung
carcinomas. Cell Motil Cytoskeleton. 65:675–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Videira PA, Correia M, Malagolini N,
Crespo HJ, Ligeiro D, Calais FM, Trindade H and Dall'Olio F:
ST3Gal.I sialyltransferase relevance in bladder cancer tissues and
cell lines. BMC Cancer. 9:3572009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carrascal MA, Severino PF, Guadalupe
Cabral M, Silva M, Ferreira JA, Calais F, Quinto H, Pen C, Ligeiro
D, Santos LL, et al: Sialyl Tn-expressing bladder cancer cells
induce a tolerogenic phenotype in innate and adaptive immune cells.
Mol Oncol. 8:753–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE Guidelines: Minimum Information for Publication of
Quantitative Real-Time PCR Experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trinchera M, Zulueta A, Caretti A and
Dall'Olio F: Control of glycosylation-related genes by DNA
methylation: The intriguing case of the B3GALT5 gene and its
distinct promoters. Biology (Basel). 3. pp. 484–497. 2014
|
|
29
|
Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge
RC and Sackstein R: CD44 is a major E-selectin ligand on human
hematopoietic progenitor cells. J Cell Biol. 153:1277–1286. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oxley SM and Sackstein R: Detection of an
L-selectin ligand on a hematopoietic progenitor cell line. Blood.
84:3299–3306. 1994.PubMed/NCBI
|
|
31
|
Dimitroff CJ, Lee JY, Schor KS, Sandmaier
BM and Sackstein R: Differential L-selectin binding activities of
human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J
Biol Chem. 276:47623–47631. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carrascal MA, Talina C, Borralho P,
Gonçalo Mineiro A, Henriques AR, Pen C, Martins M, Braga S,
Sackstein R and Videira PA: Staining of E-selectin ligands on
paraffin-embedded sections of tumor tissue. BMC Cancer. 18:4952018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin F and Prichard J: Handbook of
Practical Immunohistochemistry. Lin F and Prichard J: 2nd edition.
Springer; New York, NY: 2015
|
|
35
|
Grunnet M and Sorensen JB:
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung
Cancer. 76:138–143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McEver RP: Selectins: Initiators of
leucocyte adhesion and signalling at the vascular wall. Cardiovasc
Res. 107:331–339. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dimitroff CJ, Kupper TS and Sackstein R:
Prevention of leukocyte migration to inflamed skin with a novel
fluorosugar modifier of cutaneous lymphocyte-associated antigen. J
Clin Invest. 112:1008–1018. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Holmes EH, Ostrander GK and Hakomori S:
Biosynthesis of the sialyl-Lex determinant carried by type 2 chain
glycosphin-golipids (IV3NeuAcIII3FucnLc4, VI3NeuAcV3FucnLc6, and
VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol
Chem. 261:3737–3743. 1986.PubMed/NCBI
|
|
39
|
Shimizu T, Yonezawa S, Tanaka S and Sato
E: Expression of Lewis X-related antigens in adenocarcinomas of
lung. Histopathology. 22:549–555. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shimizu S, Suzuki H and Noguchi E: Sialyl
Lewis X-i (SLX) in the bronchoalveolar lavage fluid from patients
with lung cancer. Nihon Kyobu Shikkan Gakkai Zasshi. 30:815–820.
1992.In Japanese. PubMed/NCBI
|
|
41
|
Mizuguchi S, Inoue K, Iwata T, Nishida T,
Izumi N, Tsukioka T, Nishiyama N, Uenishi T and Suehiro S: High
serum concentrations of sialyl lewisx predict multilevel N2 disease
in non-small-cell lung cancer. Ann Surg Oncol. 13:1010–1018. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fukuoka K, Narita N and Saijo N: Increased
expression of sialyl Lewis (x) antigen is associated with distant
metastasis in lung cancer patients: Immunohistochemical study on
bronchofiber-scopic biopsy specimens. Lung Cancer. 20:109–116.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Takada A, Ohmori K, Yoneda T, Tsuyuoka K,
Hasegawa A, Kiso M and Kannagi R: Contribution of carbohydrate
antigens sialyl Lewis A and sialyl Lewis X to adhesion of human
cancer cells to vascular endothelium. Cancer Res. 53:354–361.
1993.PubMed/NCBI
|
|
44
|
Jassam SA, Maherally Z, Smith JR, Ashkan
K, Roncaroli F, Fillmore H and Pilkington GJ: CD15s/CD62E
interaction mediates the adhesion of non-small cell lung cancer
cells on brain endothelial cells: Implications for cerebral
metastasis. Int J Mol Sci. 18:E14742017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bendas G and Borsig L: Cancer cell
adhesion and metastasis: Selectins, integrins, and the inhibitory
potential of heparins. Int J Cell Biol. 2012:6767312012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Witz IP: The selectin-selectin ligand axis
in tumor progression. Cancer Metastasis Rev. 27:19–30. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Satoh H, Ishikawa H, Yamashita YT, Ohtsuka
M and Sekizawa K: Serum sialyl Lewis X-i antigen in lung
adenocarcinoma and idiopathic pulmonary fibrosis. Thorax.
57:263–266. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Trinchera M, Aronica A and Dall'Olio F:
Selectin ligands sialyllewis a and sialyl-Lewis X in
gastrointestinal cancers. Biology (Basel). 6:E162017.
|
|
49
|
Schweitzer KM, Dräger AM, van der Valk P,
Thijsen SF, Zevenbergen A, Theijsmeijer AP, van der Schoot CE and
Langenhuijsen MM: Constitutive expression of E-selectin and
vascular cell adhesion molecule-1 on endothelial cells of
hematopoietic tissues. Am J Pathol. 148:165–175. 1996.PubMed/NCBI
|
|
50
|
Weninger W, Ulfman LH, Cheng G, Souchkova
N, Quackenbush EJ, Lowe JB and von Andrian UH: Specialized
contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII
during leukocyte rolling in dermal microvessels. Immunity.
12:665–676. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kannagi R, Sakuma K, Miyazaki K, Lim KT,
Yusa A, Yin J and Izawa M: Altered expression of glycan genes in
cancers induced by epigenetic silencing and tumor hypoxia: Clues in
the ongoing search for new tumor markers. Cancer Sci. 101:586–593.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chachadi VB, Bhat G and Cheng PW:
Glycosyltransferases involved in the synthesis of MUC-associated
metastasis-promoting selectin ligands. Glycobiology. 25:963–975.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yoshihama N, Yamaguchi K, Chigita S, Mine
M, Abe M, Ishii K, Kobayashi Y, Akimoto N, Mori Y and Sugiura T: A
novel function of CD82/KAI1 in sialyl Lewis antigen-mediated
adhesion of cancer cells: Evidence for an anti-metastasis effect by
down-regulation of sialyl Lewis antigens. PLoS One.
10:e01247432015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Togayachi A, Kudo T, Ikehara Y, Iwasaki H,
Nishihara S, Andoh T, Higashiyama M, Kodama K, Nakamori S and
Narimatsu H: Up-regulation of Lewis enzyme (Fuc-TIII) and
plasma-type alpha1,3fucosyltransferase (Fuc-TVI) expression
determines the augmented expression of sialyl Lewis x antigen in
non-small cell lung cancer. Int J Cancer. 83:70–79. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Barthel SR, Wiese GK, Cho J, Opperman MJ,
Hays DL, Siddiqui J, Pienta KJ, Furie B and Dimitroff CJ: Alpha 1,3
fucosyltransferases are master regulators of prostate cancer cell
trafficking. Proc Natl Acad Sci USA. 106:19491–19496. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kannagi R, Yin J, Miyazaki K and Izawa M:
Current relevance of incomplete synthesis and neo-synthesis for
cancer-associated alteration of carbohydrate
determinants-Hakomori's concepts revisited. Biochim Biophys Acta.
1780:525–531. 2008. View Article : Google Scholar
|
|
57
|
Malagolini N, Santini D, Chiricolo M and
Dall'Olio F: Biosynthesis and expression of the Sda and sialyl
Lewis x antigens in normal and cancer colon. Glycobiology.
17:688–697. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Groux-Degroote S, Wavelet C,
Krzewinski-Recchi MA, Portier L, Mortuaire M, Mihalache A,
Trinchera M, Delannoy P, Malagolini N, Chiricolo M, et al: B4GALNT2
gene expression controls the biosynthesis of Sda and sialyl Lewis X
antigens in healthy and cancer human gastrointestinal tract. Int J
Biochem Cell Biol. 53:442–449. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Shinagawa T, Hoshino H, Taga M, Sakai Y,
Imamura Y, Yokoyama O and Kobayashi M: Clinicopathological
implications to micropapillary bladder urothelial carcinoma of the
presence of sialyl Lewis X-decorated mucin 1 in stromafacing
membranes. Urol Oncol. 35:606.e17–606.e23. 2017. View Article : Google Scholar
|
|
60
|
Burdick MM, Chu JT, Godar S and Sackstein
R: HCELL is the major E- and L-selectin ligand expressed on LS174T
colon carcinoma cells. J Biol Chem. 281:13899–13905. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Woodman N, Pinder SE, Tajadura V, Le
Bourhis X, Gillett C, Delannoy P, Burchell JM and Julien S: Two
E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor
survival of ER-negative breast cancer. Int J Oncol. 49:265–275.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sackstein R: The lymphocyte homing
receptors: Gatekeepers of the multistep paradigm. Curr Opin
Hematol. 12:444–450. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hidalgo A, Peired AJ, Wild M, Vestweber D
and Frenette PS: Complete identification of E-selectin ligands on
neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44.
Immunity. 26:477–489. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mitoma J, Miyazaki T, Sutton-Smith M,
Suzuki M, Saito H, Yeh JC, Kawano T, Hindsgaul O, Seeberger PH,
Panico M, et al: The N-glycolyl form of mouse sialyl Lewis X is
recognized by selectins but not by HECA-452 and FH6 antibodies that
were raised against human cells. Glycoconj J. 26:511–523. 2009.
View Article : Google Scholar :
|
|
65
|
Thomas SN, Zhu F, Schnaar RL, Alves CS and
Konstantopoulos K: Carcinoembryonic antigen and CD44 variant
isoforms cooperate to mediate colon carcinoma cell adhesion to E-
and L-selectin in shear flow. J Biol Chem. 283:15647–15655. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Burdick MM, Henson KA, Delgadillo LF, Choi
YE, Goetz DJ, Tees DF and Benencia F: Expression of E-selectin
ligands on circulating tumor cells: Cross-regulation with cancer
stem cell regulatory pathways? Front Oncol. 2:1032012. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Duffy MJ: Carcinoembryonic antigen as a
marker for colorectal cancer: Is it clinically useful? Clin Chem.
47:624–630. 2001.PubMed/NCBI
|
|
68
|
Wang J, Ma Y, Zhu ZH, Situ DR, Hu Y and
Rong TH: Expression and prognostic relevance of tumor
carcinoembryonic antigen in stage IB non-small cell lung cancer. J
Thorac Dis. 4:490–496. 2012.PubMed/NCBI
|
|
69
|
Beauchemin N and Arabzadeh A:
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs)
in cancer progression and metastasis. Cancer Metastasis Rev.
32:643–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Holdenrieder S, Wehnl B, Hettwer K, Simon
K, Uhlig S and Dayyani F: Carcinoembryonic antigen and
cytokeratin-19 fragments for assessment of therapy response in
non-small cell lung cancer: A systematic review and meta-analysis.
Br J Cancer. 116:1037–1045. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Li X, Asmitananda T, Gao L, Gai D, Song Z,
Zhang Y, Ren H, Yang T, Chen T and Chen M: Biomarkers in the lung
cancer diagnosis: A clinical perspective. Neoplasma. 59:500–507.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kadara H and Wistuba II: Field
cancerization in non-small cell lung cancer: Implications in
disease pathogenesis. Proc Am Thorac Soc. 9:38–42. 2012. View Article : Google Scholar
|
|
73
|
Lochhead P, Chan AT, Nishihara R, Fuchs
CS, Beck AH, Giovannucci E and Ogino S: Etiologic field effect:
Reappraisal of the field effect concept in cancer predisposition
and progression. Mod Pathol. 28:14–29. 2015. View Article : Google Scholar
|
